Prevention

Differing Guidelines for Primary Prevention Statin Therapy

Differing Guidelines for Primary Prevention Statin Therapy

Conflicting advice from the USPSTF and the ACC/AHA result in more than 9 million unnecessary statin prescriptions among US adults.

Major Bleeding Risk With Antiplatelet Drugs, Anticoagulants for Afib Compared

Major Bleeding Risk With Antiplatelet Drugs, Anticoagulants for Afib Compared

Researchers examined data from 7 randomized controlled trials and 4 cohort studies to determine the major bleeding risk with aspirin, clopidogrel, and warfarin.

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

By

Increases in body weight fluctuations were associated with greater risk for coronary and cardiovascular events and death.

CVD, Mortality Risk in Older Women Predicted by Tooth Loss and Periodontitis

CVD, Mortality Risk in Older Women Predicted by Tooth Loss and Periodontitis

By

Periodontitis was associated with an increased mortality risk while edentulism was linked with an increased cardiovascular disease risk.

Impact of Multivitamin Use on CV Health in Men

Impact of Multivitamin Use on CV Health in Men

Multivitamin use was found to have no impact on men's cardiovascular health, regardless of baseline nutritional status.

Should You Agree to Provide Preoperative Cardiology "Clearance"?

Should You Agree to Provide Preoperative Cardiology "Clearance"?

A cardiologist contemplates on the value that preoperative "clearance" brings to patients and their surgeons.

Heterogeneous Associations Between Alcohol Consumption and CVD Initial Presentation

Heterogeneous Associations Between Alcohol Consumption and CVD Initial Presentation

By

The researchers found heterogeneity in the association between recorded alcohol consumption and the initial presentation of 12 cardiovascular diseases.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

By

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Efficacy of Monthly High-Dose Vitamin D Supplementation in CVD Prevention

Efficacy of Monthly High-Dose Vitamin D Supplementation in CVD Prevention

A study sought to determine whether monthly high-dose vitamin D supplementation prevented cardiovascular disease in the general population.

Novel Multimodality Testing Strategy Improves CVD Risk Assessment

Novel Multimodality Testing Strategy Improves CVD Risk Assessment

A mutlimodal strategy combines 5 separate tests to significantly improve CVD and ASVCD risk assessment.

Pneumonia Risk Elevated With Proton Pump Inhibitor Use In Dementia

Pneumonia Risk Elevated With Proton Pump Inhibitor Use In Dementia

Independent risk factors for pneumonia included age, male gender, and underlying cerebrovascular disease, among others.

Heart Failure Risk Linked With Bone Mineral Density in Men

Heart Failure Risk Linked With Bone Mineral Density in Men

By

Total hip bone mineral density was associated with heart failure risk in black and non-black men, with an interaction by race.

Does Statins Use Through Day of Surgery Improve Coronary Artery Bypass Graft Outcomes?

Does Statins Use Through Day of Surgery Improve Coronary Artery Bypass Graft Outcomes?

CABG outcomes may be improved by using statins through day-of-surgery.

Automated External Defibrillator Requirements in US Schools

Automated External Defibrillator Requirements in US Schools

Only 17 of 50 US states require installation of automated external defibrillator devices.

Dissecting the Latest Trends and Controversies in Cardiovascular Nutrition

Dissecting the Latest Trends and Controversies in Cardiovascular Nutrition

By

Recent evidence clearly indicates that patients should be eating whole foods rather than attempting to get vitamins and antioxidants from dietary supplements.

Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis

Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis

By

Researchers noted that the relative risk of heart failure increased following a patient's RA diagnosis.

Reduced Smoking Rates Worldwide Following Global Tobacco Control Treaty

Reduced Smoking Rates Worldwide Following Global Tobacco Control Treaty

Participating countries agreed to introduce policies including high tobacco taxes and smoke-free public spaces.

Utility of Hydration in Mitigating Risk of Contrast-Induced Nephropathy

Utility of Hydration in Mitigating Risk of Contrast-Induced Nephropathy

By

High-risk patients experienced the same rate of contrast-induced nepropathy as patients who received usual care when guideline-recommended prophylactic hydration was not utilized, according to researchers.

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

By

A decline in function status occurred an average of 2 years before hospitalization for myocardial infarction, and 3 years before heart failure and stroke.

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

By

Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.

Analyzing Patient Heterogeneity Upon Antihypertensive Therapy Initiation to Personalize Prognosis

Analyzing Patient Heterogeneity Upon Antihypertensive Therapy Initiation to Personalize Prognosis

By

Patients with higher baseline blood pressure had higher 6-month combined cardiovascular disease incidence after adjustments.

 Does Prophylactic Hydration Actually Prevent Contrast-Induced Nephropathy?

Does Prophylactic Hydration Actually Prevent Contrast-Induced Nephropathy?

By

Study results question whether or not prophylactic hydration should have been introduced as standard of care.

Higher BMI Linked With Lower Mortality in Adult Congenital Heart Disease

Higher BMI Linked With Lower Mortality in Adult Congenital Heart Disease

By

Higher BMI was associated with lower all-cause and cardiac mortality in adults with congenital heart disease, even after adjusting for age, defect complexity, cyanosis, and objective exercise capacity.

HIV Infection Associated With Elevated Cardiovascular Disease Risk

HIV Infection Associated With Elevated Cardiovascular Disease Risk

Those with HIV infection experience an elevated risk for CVD, potentially exacerbated by the use of certain antiretroviral therapies.

Cardiometabolic Risk Increased With Maternal Hyperglycemia In Pregnancy

Cardiometabolic Risk Increased With Maternal Hyperglycemia In Pregnancy

Children whose mothers had gestational diabetes were more likely to be overweight or obese or have elevated BMI, blood pressure, or abnormal glucose tolerance.

Evaluating Cangrelor Vs Clopidogrel In Percutaneous Coronary Intervention

Evaluating Cangrelor Vs Clopidogrel In Percutaneous Coronary Intervention

By

Researchers studied the safety and efficacy of cangrelor in patients receiving unfractionated heparin for PCI.

Statin Eligibility Requirements In African Americans With Atherosclerosis

Statin Eligibility Requirements In African Americans With Atherosclerosis

According to ACC/AHA Guidelines presented at ACC 2017, targeted imaging should be used to personalize statin recommendation programs.

Cognition Not Adversely Affected by Evolocumab With Statin Therapy

Cognition Not Adversely Affected by Evolocumab With Statin Therapy

By

No differences were seen in measures of executive function between the evolocumab and placebo groups.

LDL-C Lowered Below Current Targets Beneficial to Atherosclerotic CVD

LDL-C Lowered Below Current Targets Beneficial to Atherosclerotic CVD

By

Evolocumab reduced LDL-C levels by 59% and lowered the risk of CV death, MI, stroke, hospitalization for unstable angina, or coronary revascularization by 15%.

Bococizumab Reduced Cardiovascular Events in High-Risk But Not Low-Risk Patients

Bococizumab Reduced Cardiovascular Events in High-Risk But Not Low-Risk Patients

By

In the combined SPIRE trials, the mean change in LDL-C levels was −56.0% in the bococizumab group and +2.9% in the placebo group.

Sign Up for Free e-Newsletters